Sutro Biopharma Total Assets 2017-2022 | STRO
Sutro Biopharma total assets from 2017 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Sutro Biopharma Annual Total Assets
(Millions of US $) |
| 2021 |
$341 |
| 2020 |
$394 |
| 2019 |
$156 |
| 2018 |
$223 |
| 2017 |
$41 |
| 2016 |
$69 |
Sutro Biopharma Quarterly Total Assets
(Millions of US $) |
| 2022-03-31 |
$304 |
| 2021-12-31 |
$341 |
| 2021-09-30 |
$371 |
| 2021-06-30 |
$360 |
| 2021-03-31 |
$359 |
| 2020-12-31 |
$394 |
| 2020-09-30 |
$307 |
| 2020-06-30 |
$278 |
| 2020-03-31 |
$154 |
| 2019-12-31 |
$156 |
| 2019-09-30 |
$172 |
| 2019-06-30 |
$189 |
| 2019-03-31 |
$202 |
| 2018-12-31 |
$223 |
| 2018-09-30 |
$145 |
| 2018-06-30 |
$0 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$0 |
| 2017-09-30 |
$0 |
| 2016-12-31 |
$69 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.216B |
$0.062B |
|
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
|
